ESPR

insider transactions

Esperion Therapeutics, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

-76.2K

0 buy · 76.2K sell

Net value · 90d

-$240.4K

$0 in · $240.4K out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 76.2K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Sell·S
Jun 17, 26

Benjamin Looker

Chief Legal Officer

$37.3K

11.8K sh · $3.16

Own -2%
Sell·S
Jun 17, 26

Sheldon L. Koenig KEY

President and CEO

$169.1K

53.6K sh · $3.16

Own -2%
Sell·S
Jun 17, 26

Benjamin Halladay KEY

Chief Financial Officer

$34.0K

10.8K sh · $3.16

Own -2%
Grant·A
May 28, 26

John Craig Thompson

Director

$0

79.9K sh

Own New
Grant·A
May 28, 26

Jay Shepard

Director

$0

79.9K sh

Own +94%
Grant·A
May 28, 26

Robert E. Hoffman

Director

$0

79.9K sh

Own +1513%
Grant·A
May 28, 26

Seth H. Z. Fischer

Director

$0

79.9K sh

Own +131%
Grant·A
May 28, 26

Martin J Carroll

Director

$0

79.9K sh

Own +82%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 17, 2026	Benjamin Looker	Chief Legal Officer	Sell S	11.8K	-2%	$3.16	$37.3K
Jun 17, 2026	Sheldon L. Koenig KEY	President and CEO	Sell S	53.6K	-2%	$3.16	$169.1K
Jun 17, 2026	Benjamin Halladay KEY	Chief Financial Officer	Sell S	10.8K	-2%	$3.16	$34.0K
May 28, 2026	John Craig Thompson	Director	Grant A	79.9K	New	—	$0
May 28, 2026	Jay Shepard	Director	Grant A	79.9K	+94%	—	$0
May 28, 2026	Robert E. Hoffman	Director	Grant A	79.9K	+1513%	—	$0
May 28, 2026	Seth H. Z. Fischer	Director	Grant A	79.9K	+131%	—	$0
May 28, 2026	Martin J Carroll	Director	Grant A	79.9K	+82%	—	$0

About ESPR insider trading

This page tracks insider transactions for Esperion Therapeutics, Inc. (ESPR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.